CLDN14 and Hypercalciuria: This activates a signaling cascade where the expression of Claudin-14 disrupts Mg reabsorption, contributing to hypermagnesuria and hypercalciuria [64, 65], which can further exacerbate existing subclinical hypomagnesemia.